150 related articles for article (PubMed ID: 23641870)
1. Differential specificity of HIV incidence assays in HIV subtypes A and D-infected individuals from Rakai, Uganda.
Mullis CE; Munshaw S; Grabowski MK; Eshleman SH; Serwadda D; Brookmeyer R; Nalugoda F; Kigozi G; Kagaayi J; Tobian AA; Wawer M; Gray RH; Quinn TC; Laeyendecker O
AIDS Res Hum Retroviruses; 2013 Aug; 29(8):1146-50. PubMed ID: 23641870
[TBL] [Abstract][Full Text] [Related]
2. Impact of HIV subtype on performance of the limiting antigen-avidity enzyme immunoassay, the bio-rad avidity assay, and the BED capture immunoassay in Rakai, Uganda.
Longosz AF; Serwadda D; Nalugoda F; Kigozi G; Franco V; Gray RH; Quinn TC; Eshleman SH; Laeyendecker O
AIDS Res Hum Retroviruses; 2014 Apr; 30(4):339-44. PubMed ID: 24083837
[TBL] [Abstract][Full Text] [Related]
3. Specificity of four laboratory approaches for cross-sectional HIV incidence determination: analysis of samples from adults with known nonrecent HIV infection from five African countries.
Laeyendecker O; Brookmeyer R; Mullis CE; Donnell D; Lingappa J; Celum C; Baeten JM; Campbell MS; Essex M; de Bruyn G; Farquhar C; Quinn TC; Eshleman SH;
AIDS Res Hum Retroviruses; 2012 Oct; 28(10):1177-83. PubMed ID: 22283149
[TBL] [Abstract][Full Text] [Related]
4. Improved testing of recent HIV-1 infections with the BioRad avidity assay compared to the limiting antigen avidity assay and BED Capture enzyme immunoassay: evaluation using reference sample panels from the German Seroconverter Cohort.
Hauser A; Santos-Hoevener C; Meixenberger K; Zimmermann R; Somogyi S; Fiedler S; Hofmann A; Bartmeyer B; Jansen K; Hamouda O; Bannert N; Kuecherer C
PLoS One; 2014; 9(6):e98038. PubMed ID: 24892795
[TBL] [Abstract][Full Text] [Related]
5. Immune responses in Ugandan women infected with subtypes A and D HIV using the BED capture immunoassay and an antibody avidity assay.
Longosz AF; Morrison CS; Chen PL; Arts E; Nankya I; Salata RA; Franco V; Quinn TC; Eshleman SH; Laeyendecker O
J Acquir Immune Defic Syndr; 2014 Apr; 65(4):390-6. PubMed ID: 24583613
[TBL] [Abstract][Full Text] [Related]
6. HIV incidence determination in the United States: a multiassay approach.
Laeyendecker O; Brookmeyer R; Cousins MM; Mullis CE; Konikoff J; Donnell D; Celum C; Buchbinder SP; Seage GR; Kirk GD; Mehta SH; Astemborski J; Jacobson LP; Margolick JB; Brown J; Quinn TC; Eshleman SH
J Infect Dis; 2013 Jan; 207(2):232-9. PubMed ID: 23129760
[TBL] [Abstract][Full Text] [Related]
7. Factors associated with incorrect identification of recent HIV infection using the BED capture immunoassay.
Laeyendecker O; Brookmeyer R; Oliver AE; Mullis CE; Eaton KP; Mueller AC; Jacobson LP; Margolick JB; Brown J; Rinaldo CR; Quinn TC; Eshleman SH;
AIDS Res Hum Retroviruses; 2012 Aug; 28(8):816-22. PubMed ID: 22014036
[TBL] [Abstract][Full Text] [Related]
8. Estimating False-Recent Classification for the Limiting-Antigen Avidity EIA and BED-Capture Enzyme Immunoassay in Vietnam: Implications for HIV-1 Incidence Estimates.
Shah NS; Duong YT; Le LV; Tuan NA; Parekh BS; Ha HTT; Pham QD; Cuc CTT; Dobbs T; Tram TH; Lien TTX; Wagar N; Yang C; Martin A; Wolfe M; Hien NT; Kim AA
AIDS Res Hum Retroviruses; 2017 Jun; 33(6):546-554. PubMed ID: 28193090
[TBL] [Abstract][Full Text] [Related]
9. Validation of the Limiting Antigen Avidity Assay to Estimate Level and Trends in HIV Incidence in an A/D Epidemic in Rakai, Uganda.
Laeyendecker O; Gray RH; Grabowski MK; Reynolds SJ; Ndyanabo A; Ssekasanvu J; Fernandez RE; Wawer MJ; Serwadda D; Quinn TC
AIDS Res Hum Retroviruses; 2019 Apr; 35(4):364-367. PubMed ID: 30560723
[TBL] [Abstract][Full Text] [Related]
10. Evaluation of the false recent classification rates of multiassay algorithms in estimating HIV type 1 subtype C incidence.
Moyo S; LeCuyer T; Wang R; Gaseitsiwe S; Weng J; Musonda R; Bussmann H; Mine M; Engelbrecht S; Makhema J; Marlink R; Baum MK; Novitsky V; Essex M
AIDS Res Hum Retroviruses; 2014 Jan; 30(1):29-36. PubMed ID: 23937344
[TBL] [Abstract][Full Text] [Related]
11. Effect of natural and ARV-induced viral suppression and viral breakthrough on anti-HIV antibody proportion and avidity in patients with HIV-1 subtype B infection.
Wendel SK; Mullis CE; Eshleman SH; Blankson JN; Moore RD; Keruly JC; Brookmeyer R; Quinn TC; Laeyendecker O
PLoS One; 2013; 8(2):e55525. PubMed ID: 23437058
[TBL] [Abstract][Full Text] [Related]
12. Evaluation of the Performance of Three Biomarker Assays for Recent HIV Infection Using a Well-Characterized HIV-1 Subtype C Incidence Cohort.
Gonese E; Kilmarx PH; van Schalkwyk C; Grebe E; Mutasa K; Ntozini R; Parekh B; Dobbs T; Duong Pottinger Y; Masciotra S; Owen M; Nachega JB; van Zyl G; Hargrove JW
AIDS Res Hum Retroviruses; 2019 Jul; 35(7):615-627. PubMed ID: 30938164
[TBL] [Abstract][Full Text] [Related]
13. Application of the BED capture enzyme immunoassay for HIV incidence estimation among female sex workers in Kaiyuan City, China, 2006-2007.
Xu J; Wang H; Jiang Y; Ding G; Jia M; Wang G; Chu J; Smith K; Sharp GB; Chen RY; Jin X; Dong R; Han X; Shang H; Wang N
Int J Infect Dis; 2010 Jul; 14(7):e608-12. PubMed ID: 20102792
[TBL] [Abstract][Full Text] [Related]
14. [A system review on the application of BED-capture enzyme immunoassay in detecting new HIV-1 infection].
Tao J; Zhao J; Liu Y; Meng LZ; Yu SC; Jiang Y; Xiao Y
Zhonghua Liu Xing Bing Xue Za Zhi; 2011 Feb; 32(2):177-81. PubMed ID: 21518629
[TBL] [Abstract][Full Text] [Related]
15. Investigating the utility of the HIV-1 BED capture enzyme immunoassay using cross-sectional and longitudinal seroconverter specimens from Africa.
Karita E; Price M; Hunter E; Chomba E; Allen S; Fei L; Kamali A; Sanders EJ; Anzala O; Katende M; Ketter N;
AIDS; 2007 Feb; 21(4):403-8. PubMed ID: 17301558
[TBL] [Abstract][Full Text] [Related]
16. Comparison of methods to detect recent HIV type 1 infection in cross-sectionally collected specimens from a cohort of female sex workers in the Dominican Republic.
Gupta SB; Murphy G; Koenig E; Adon C; Beyrer C; Celentano D; Khawaja S; Sifakis F; Parry JV; Straus W
AIDS Res Hum Retroviruses; 2007 Dec; 23(12):1475-80. PubMed ID: 18160004
[TBL] [Abstract][Full Text] [Related]
17. Development and Evaluation of a Modified Fourth-Generation Human Immunodeficiency Virus Enzyme Immunoassay for Cross-Sectional Incidence Estimation in Clade B Populations.
Kirkpatrick AR; Patel EU; Celum CL; Moore RD; Blankson JN; Mehta SH; Kirk GD; Margolick JB; Quinn TC; Eshleman SH; Laeyendecker O
AIDS Res Hum Retroviruses; 2016 Aug; 32(8):756-62. PubMed ID: 26988426
[TBL] [Abstract][Full Text] [Related]
18. Dual testing algorithm of BED-CEIA and AxSYM Avidity Index assays performs best in identifying recent HIV infection in a sample of Rwandan sex workers.
Braunstein SL; Nash D; Kim AA; Ford K; Mwambarangwe L; Ingabire CM; Vyankandondera J; van de Wijgert JH
PLoS One; 2011 Apr; 6(4):e18402. PubMed ID: 21532753
[TBL] [Abstract][Full Text] [Related]
19. Serologic and phylogenetic characterization of HIV-1 subtypes in Uganda.
Brennan CA; Lund JK; Golden A; Yamaguchi J; Vallari AS; Phillips JF; Kataaha PK; Jackson JB; Devare SG
AIDS; 1997 Dec; 11(15):1823-32. PubMed ID: 9412700
[TBL] [Abstract][Full Text] [Related]
20. Effect of CD4+ T cell count and antiretroviral treatment on two serological HIV incidence assays.
Hladik W; Olara D; Mermin J; Moore D; Were W; Alexander L; Downing R
AIDS Res Hum Retroviruses; 2012 Jan; 28(1):95-9. PubMed ID: 21314476
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
